Patent · US Active

Broadly neutralizing antibody and uses thereof

US10093720B2 · kind B2 · utility

4Cited by

0References

6Claims

0Family size

Assignees

International AIDS Vaccine Initiative, Inc. · US
THE SCRIPPS RESEARCH INSTITUTE · US
Cornell University · IT

Inventors

Dennis R. Burton · Village of La Jolla, US
Marit J. Van Gils · Village of La Jolla, US
Wayne Koff · Stony Brook, US
Pascal Raymond Georges Poignard · San Diego, US
Rogier W. Sanders · Ithaca, US
Melissa Danielle De Jean De St. Marcel Simek-Lemos · Brooklyn, US
Devin Sok · Village of La Jolla, US

Key dates

Filing date	Jun 5, 2015
Grant date	Oct 9, 2018
Priority date	—
Expiry date	Jul 9, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to an exceptionally broad and potent neutralizing antibody which may comprise cross-clade neutralizing coverage of 83% at a median IC50 of 0.003 μg/ml, compositions containing the same and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.